Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial
Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page
- Check5 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedA banner announces the NIH transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check47 days agoChange DetectedA 403 Forbidden page is now shown when loading the study record, replacing the usual content with an access-restricted notice. This indicates an access restriction rather than a change to the study data.SummaryDifference17%

- Check68 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a minor update to the page template/version. This change does not affect the study details or user-facing information.SummaryDifference0.1%

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.